These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22314535)

  • 1. Expression turnover profiling to monitor the antifungal activities of amphotericin B, voriconazole, and micafungin against Aspergillus fumigatus.
    Zhao Y; Paderu P; Park S; Dukhan A; Senter M; Perlin DS
    Antimicrob Agents Chemother; 2012 May; 56(5):2770-2. PubMed ID: 22314535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro Interactions between Target of Rapamycin Kinase Inhibitor and Antifungal Agents against Aspergillus Species.
    Gao L; Ding X; Liu Z; Wu Q; Zeng T; Sun Y
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3813-6. PubMed ID: 26976874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphotericin B- and voriconazole-echinocandin combinations against Aspergillus spp.: Effect of serum on inhibitory and fungicidal interactions.
    Elefanti A; Mouton JW; Verweij PE; Tsakris A; Zerva L; Meletiadis J
    Antimicrob Agents Chemother; 2013 Oct; 57(10):4656-63. PubMed ID: 23856768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase-dependent antifungal activity against Aspergillus fumigatus developing multicellular filamentous biofilms.
    Mowat E; Lang S; Williams C; McCulloch E; Jones B; Ramage G
    J Antimicrob Chemother; 2008 Dec; 62(6):1281-4. PubMed ID: 18819968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus.
    Krishnan S; Manavathu EK; Chandrasekar PH
    J Antimicrob Chemother; 2005 Jun; 55(6):914-20. PubMed ID: 15824093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
    Nishi I; Sunada A; Toyokawa M; Asari S; Iwatani Y
    J Infect Chemother; 2009 Feb; 15(1):1-5. PubMed ID: 19280292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of echinocandins, amphotericin B and voriconazole against fluconazole-susceptible and fluconazole-resistant Brazilian Candida glabrata isolates.
    Mario DA; Denardi LB; Bandeira LA; Antunes MS; Santurio JM; Severo LC; Alves SH
    Mem Inst Oswaldo Cruz; 2012 May; 107(3):433-6. PubMed ID: 22510843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro efficacy of the combination of voriconazole and anidulafungin against voriconazole-resistant cyp51A mutants of Aspergillus fumigatus.
    Krishnan-Natesan S; Wu W; Chandrasekar PH
    Diagn Microbiol Infect Dis; 2012 Jun; 73(2):135-7. PubMed ID: 22608136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scanning Quadrupole Data-Independent Acquisition, Part B: Application to the Analysis of the Calcineurin-Interacting Proteins during Treatment of Aspergillus fumigatus with Azole and Echinocandin Antifungal Drugs.
    Juvvadi PR; Moseley MA; Hughes CJ; Soderblom EJ; Lennon S; Perkins SR; Thompson JW; Geromanos SJ; Wildgoose J; Richardson K; Langridge JI; Vissers JPC; Steinbach WJ
    J Proteome Res; 2018 Feb; 17(2):780-793. PubMed ID: 29251506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans.
    Manavathu EK; Ramesh MS; Baskaran I; Ganesan LT; Chandrasekar PH
    J Antimicrob Chemother; 2004 Feb; 53(2):386-9. PubMed ID: 14729762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The evaluation of in vitro pharmacodynamic properties of amphotericin B, voriconazole and caspofungin against A. fumigatus isolates by the conventional and colorimetric time-kill assays.
    Kiraz N; Oz Y; Dag I
    Med Mycol; 2011 Aug; 49(6):594-601. PubMed ID: 21299374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.
    Cuenca-Estrella M; Gomez-Lopez A; Garcia-Effron G; Alcazar-Fuoli L; Mellado E; Buitrago MJ; Rodriguez-Tudela JL
    Antimicrob Agents Chemother; 2005 Mar; 49(3):1232-5. PubMed ID: 15728937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
    Meletiadis J; Al-Saigh R; Velegraki A; Walsh TJ; Roilides E; Zerva L
    Antimicrob Agents Chemother; 2012 Jan; 56(1):403-10. PubMed ID: 22064546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of efficacy of antifungals against Aspergillus fumigatus: value of real-time bioluminescence imaging.
    Galiger C; Brock M; Jouvion G; Savers A; Parlato M; Ibrahim-Granet O
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3046-59. PubMed ID: 23587947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of eight antifungal drugs against 106 waterborne and cutaneous exophiala species.
    Najafzadeh MJ; Saradeghi Keisari M; Vicente VA; Feng P; Shamsian SA; Rezaei-Matehkolaei A; de Hoog GS; Curfs-Breuker I; Meis JF
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6395-8. PubMed ID: 24100491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory and fungicidal effects of antifungal drugs against Aspergillus species in the presence of serum.
    Elefanti A; Mouton JW; Krompa K; Al-Saigh R; Verweij PE; Zerva L; Meletiadis J
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1625-31. PubMed ID: 23318807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal susceptibilities of Aspergillus fumigatus clinical isolates obtained in Nagasaki, Japan.
    Tashiro M; Izumikawa K; Minematsu A; Hirano K; Iwanaga N; Ide S; Mihara T; Hosogaya N; Takazono T; Morinaga Y; Nakamura S; Kurihara S; Imamura Y; Miyazaki T; Nishino T; Tsukamoto M; Kakeya H; Yamamoto Y; Yanagihara K; Yasuoka A; Tashiro T; Kohno S
    Antimicrob Agents Chemother; 2012 Jan; 56(1):584-7. PubMed ID: 22024829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-azole resistance in Aspergillus fumigatus.
    Howard SJ; Webster I; Moore CB; Gardiner RE; Park S; Perlin DS; Denning DW
    Int J Antimicrob Agents; 2006 Nov; 28(5):450-3. PubMed ID: 17034993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antifungal susceptibility of Cladophialophora carrionii, an agent of human chromoblastomycosis.
    Deng S; de Hoog GS; Badali H; Yang L; Najafzadeh MJ; Pan B; Curfs-Breuker I; Meis JF; Liao W
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1974-7. PubMed ID: 23380718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.